Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts (Q39152052)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 May 2013

Language	Label	Description	Also known as
English	Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts	scientific article published on 15 May 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

0 references

author name string

Ah Young Jun

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Hyun-Jeong Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Kwang-Kyun Park

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Kun Ho Son

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Dong Hwa Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Mi-Hee Woo

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Won-Yoon Chung

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

15 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1-13

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Bone remodeling

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Bone metastasis: pathogenesis and therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Metastasis to bone: causes, consequences and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

The evolving role of natural products in drug discovery

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Chemistry and bioactivity of Flos Magnoliae, a Chinese herb for rhinitis and sinusitis

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

5-lipoxygenase-inhibitory constituents from Schizandra fructus and Magnolia flos

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

The clinical course of bone metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Mechanisms of breast cancer bone metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Advances in the biology of bone metastasis: how the skeleton affects tumor behavior

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

The role of zoledronic acid in cancer: clinical studies in the treatment and prevention of bone metastases

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Treatment of breast cancer with bone metastasis: bisphosphonate treatment - current and future

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

New molecular targets in bone metastases.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Basic mechanisms responsible for osteolytic and osteoblastic bone metastases

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Mechanisms of bone metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

The multifaceted actions of PTHrP in skeletal metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

OPG/RANKL/RANK Pathway as a Therapeutic Target in Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-9969-0

21 January 2018

Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23673814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23673814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two new stereoisomers of Tetrahydrofuranoid lignans from the flower buds of Magnolia fargesii

1 reference

https://pubmed.ncbi.nlm.nih.gov/23673814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23673814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effect of Flos magnoliae extract on multiple low dose streptozotocin-induced type 1 diabetes development and cytokine-induced beta-cell damage

1 reference

https://pubmed.ncbi.nlm.nih.gov/23673814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemical characterization of Magnolia biondii (Flos Magnoliae, Xin Yi).

1 reference

https://pubmed.ncbi.nlm.nih.gov/23673814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The distribution of secondary growths in cancer of the breast. 1889

1 reference

https://pubmed.ncbi.nlm.nih.gov/23673814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical utility of biochemical markers of bone remodeling

1 reference

https://pubmed.ncbi.nlm.nih.gov/23673814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of inducible nitric oxide synthase expression by furfuran lignans from flower buds of Magnolia fargesii in BV-2 microglial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23673814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extract of Magnoliae Flos inhibits ovariectomy-induced osteoporosis by blocking osteoclastogenesis and reducing osteoclast-mediated bone resorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/23673814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-013-9969-0

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39152052&oldid=2202618711"